Logo
LEBER CONGENITAL AMAUROSIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)
  2. / Industry Reports
  3. Leber Congenital Amaurosis Market Analysis
all report title image

LEBER CONGENITAL AMAUROSIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Leber Congenital Amaurosis Market, By Treatment Type (Gene Therapy, Pharmaceutical Drugs, Retinal Prosthesis, Assistive Devices, and Others), By Target Gene (RPE65, GUCY2D, AIPL1, RPGRIP1, CEP290, and Other Genes), By End User (Hospitals, Specialized Eye Clinics, Ophthalmology Research Centers, Home Care Settings, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Aug 2024
  • Code : CMI7271
  • Pages :140
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Leber Congenital Amaurosis Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • Novartis
  • Biogen
  • Spark Therapeutics
  • GenSight Biologics
  • Roche
  • AbbVie
  • Regeneron Pharmaceuticals
  • Pfizer
  • Astellas Pharma
  • Santen Pharmaceutical
  • Orphan Biovitrum
  • Apellis Pharmaceuticals
  • Gilead Sciences
  • Eyenovia
  • Avexis
  • Regenxbio
  • Horizon Therapeutics
  • Aerie Pharmaceuticals
  • Ophthotech Corporation
  • Aldeyra Therapeutics

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.